A study done by Blaheta et al. on the prostate cancer cell model (PC3) demonstrated that HCMV acts on the invasive properties of the prostatic cancerous cell line PC3, and this carcinogenic process is promoted by elevated c-Myc levels [81]. The gene discussed is MYC; the disease is prostate cancer.